New York State Teachers Retirement System lifted its stake in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 1.3% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 145,141 shares of the semiconductor company’s stock after acquiring an additional 1,854 shares during the period. New York State Teachers Retirement System owned 0.08% of Synopsys worth $57,546,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds have also recently modified their holdings of the company. Sankala Group LLC acquired a new position in Synopsys in the 4th quarter valued at about $25,000. Thurston Springer Miller Herd & Titak Inc. acquired a new stake in shares of Synopsys during the 4th quarter worth approximately $28,000. Caitong International Asset Management Co. Ltd acquired a new stake in shares of Synopsys during the 4th quarter worth approximately $28,000. Atlas Capital Advisors Inc. purchased a new stake in shares of Synopsys during the 4th quarter valued at approximately $32,000. Finally, Osbon Capital Management LLC purchased a new stake in shares of Synopsys during the 4th quarter valued at approximately $34,000. Hedge funds and other institutional investors own 85.47% of the company’s stock.
Analyst Ratings Changes
Several research analysts recently weighed in on the company. Weiss Ratings reiterated a “hold (c-)” rating on shares of Synopsys in a research report on Monday, June 8th. Zacks Research upgraded Synopsys from a “hold” rating to a “strong-buy” rating in a research report on Tuesday. KeyCorp reaffirmed an “overweight” rating on shares of Synopsys in a research note on Thursday, May 28th. Piper Sandler upgraded Synopsys from a “neutral” rating to an “overweight” rating and increased their price target for the stock from $450.00 to $550.00 in a report on Tuesday, June 23rd. Finally, Robert W. Baird set a $558.00 price objective on Synopsys in a research report on Thursday, May 28th. One investment analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $570.06.
Synopsys Price Performance
Synopsys stock opened at $437.16 on Friday. The company has a market capitalization of $83.71 billion, a PE ratio of 101.19, a price-to-earnings-growth ratio of 2.57 and a beta of 1.22. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.32 and a current ratio of 1.43. Synopsys, Inc. has a fifty-two week low of $376.18 and a fifty-two week high of $651.73. The firm has a 50 day moving average price of $482.19 and a 200 day moving average price of $461.34.
Synopsys (NASDAQ:SNPS – Get Free Report) last released its quarterly earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 EPS for the quarter, topping analysts’ consensus estimates of $3.15 by $0.20. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.The company had revenue of $2.28 billion for the quarter, compared to analysts’ expectations of $2.25 billion. During the same period in the prior year, the firm earned $3.67 earnings per share. The firm’s revenue was up 41.9% compared to the same quarter last year. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. Research analysts expect that Synopsys, Inc. will post 10.65 earnings per share for the current year.
Insider Transactions at Synopsys
In other news, CFO Shelagh Glaser sold 3,394 shares of the stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the sale, the chief financial officer owned 14,358 shares of the company’s stock, valued at approximately $6,461,387.16. This represents a 19.12% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of the firm’s stock in a transaction that occurred on Monday, June 15th. The shares were sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the completion of the transaction, the chief executive officer directly owned 75,020 shares of the company’s stock, valued at approximately $34,431,179.20. The trade was a 16.29% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Company insiders own 0.56% of the company’s stock.
Synopsys Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front?end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape?out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
See Also
- Five stocks we like better than Synopsys
- AST SpaceMobile’s Japan Catalyst Puts Its Rollout Story Back in Focus
- Gold and Silver Recovery—3 Precious Metals Stocks for H2 2026
- Klarna’s Google Court Win Could Give Its BNPL Story a Needed Cash Catalyst
- Why Kroger’s Giant Eagle Deal Could Change Everything
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
